OrganiGram Holdings Valuation
| OGI Stock | CAD 2.25 0.11 5.14% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. OrganiGram Holdings holds a recent Real Value of C$1.91 per share. The prevailing price of the company is C$2.25. Our model determines the value of OrganiGram Holdings from analyzing the company fundamentals such as Shares Outstanding of 126.16 M, operating margin of (0.12) %, and Return On Equity of -0.55 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting OrganiGram Holdings' valuation include:
Price Book 0.9091 | Enterprise Value | Enterprise Value Ebitda (1.42) | Price Sales 1.8094 | Forward PE 14.5773 |
Overvalued
Today
Please note that OrganiGram Holdings' price fluctuation is very risky at this time. Calculation of the real value of OrganiGram Holdings is based on 3 months time horizon. Increasing OrganiGram Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since OrganiGram Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OrganiGram Stock. However, OrganiGram Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.25 | Real 1.91 | Hype 2.26 | Naive 2.18 |
The intrinsic value of OrganiGram Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OrganiGram Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OrganiGram Holdings helps investors to forecast how OrganiGram stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OrganiGram Holdings more accurately as focusing exclusively on OrganiGram Holdings' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use OrganiGram Holdings' intrinsic value based on its ongoing forecasts of OrganiGram Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against OrganiGram Holdings' closest peers.
OrganiGram Holdings Cash |
|
OrganiGram Valuation Trend
Knowing OrganiGram Holdings' actual value is paramount for traders when making sound investment determinations. Using both OrganiGram Holdings' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
OrganiGram Holdings Total Value Analysis
OrganiGram Holdings is now forecasted to have takeover price of 174.55 M with market capitalization of 269.98 M, debt of 60 K, and cash on hands of 44.78 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the OrganiGram Holdings fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
174.55 M | 269.98 M | 60 K | 44.78 M |
OrganiGram Holdings Investor Information
About 34.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. OrganiGram Holdings has Price/Earnings To Growth (PEG) ratio of 0.04. The entity recorded a loss per share of 0.48. The firm had not issued any dividends in recent years. OrganiGram Holdings had 1:4 split on the 7th of July 2023. Based on the key indicators related to OrganiGram Holdings' liquidity, profitability, solvency, and operating efficiency, OrganiGram Holdings may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.OrganiGram Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. OrganiGram Holdings has an asset utilization ratio of 39.19 percent. This suggests that the Company is making C$0.39 for each dollar of assets. An increasing asset utilization means that OrganiGram Holdings is more efficient with each dollar of assets it utilizes for everyday operations.OrganiGram Holdings Ownership Allocation
OrganiGram Holdings owns a total of 126.16 Million outstanding shares. OrganiGram Holdings has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.OrganiGram Holdings Profitability Analysis
The company reported the revenue of 159.84 M. Net Loss for the year was (45.44 M) with profit before overhead, payroll, taxes, and interest of 35.07 M.About OrganiGram Holdings Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of OrganiGram Holdings. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of OrganiGram Holdings based exclusively on its fundamental and basic technical indicators. By analyzing OrganiGram Holdings's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of OrganiGram Holdings's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of OrganiGram Holdings. We calculate exposure to OrganiGram Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OrganiGram Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 54.7 M | 57.4 M | |
| Pretax Profit Margin | (0.10) | (0.10) | |
| Operating Profit Margin | (0.27) | (0.28) | |
| Net Loss | (0.10) | (0.10) | |
| Gross Profit Margin | 0.22 | 0.21 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.